Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
$406M |
| 2 |
Baidu
BIDU
|
$382M |
| 3 |
AGN
Allergan plc
AGN
|
$366M |
| 4 |
Bristol-Myers Squibb
BMY
|
$322M |
| 5 |
NextEra Energy, Inc.
NEE
|
$312M |
Top Sells
| 1 |
Tesla
TSLA
|
$1.66B |
| 2 |
Meta Platforms (Facebook)
META
|
$370M |
| 3 |
Pfizer
PFE
|
$343M |
| 4 |
Gilead Sciences
GILD
|
$331M |
| 5 |
Amazon
AMZN
|
$282M |
Sector Composition
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.73% |
| 3 | Consumer Staples | 9.8% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $3.68B | 3.57% | 65,992,111 +5,781,450 | +10% | +$322M |
|
2
Novo Nordisk
NVO
$251B
| $1.68B | 1.63% | 27,860,226 +1,643,200 | +6% | +$98.9M |
|
3
Vertex Pharmaceuticals
VRTX
$100B
| $1.63B | 1.59% | 6,859,682 -216,900 | -3% | -$51.6M |
|
4
VeriSign
VRSN
$25.5B
| $1.46B | 1.42% | 8,105,290 -165,400 | -2% | -$29.8M |
|
5
Biogen
BIIB
$19.4B
| $1.42B | 1.37% | 4,473,912 -95,994 | -2% | -$30.4M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $1.26B | 1.22% | 7,089,144 +2,069,332 | +41% | +$366M |
|
7
Chipotle Mexican Grill
CMG
$56.5B
| $1.2B | 1.17% | 1,839,242 +75,700 | +4% | +$49.5M |
|
8
Walmart
WMT
$774B
| $1.11B | 1.08% | 9,802,214 +875,377 | +10% | +$99.5M |
|
9
Humana
HUM
$36.5B
| $1.11B | 1.08% | 3,529,142 +577,900 | +20% | +$181M |
|
10
AbbVie
ABBV
$372B
| $1.03B | 1% | 13,555,849 +1,759,105 | +15% | +$134M |
|
|
11
Gilead Sciences
GILD
$140B
| $937M | 0.91% | 12,531,209 -4,431,735 | -26% | -$331M |
|
12
Palo Alto Networks
PANW
$127B
| $889M | 0.86% | 5,419,351 -243,100 | -4% | -$39.9M |
|
13
Atlassian
TEAM
$46.6B
| $883M | 0.86% | 6,434,024 +352,100 | +6% | +$48.3M |
|
14
GSK
GSK
$79.9B
| $874M | 0.85% | 23,076,454 +4,048,855 | +21% | +$153M |
|
15
Monster Beverage
MNST
$60.9B
| $766M | 0.74% | 13,606,592 +2,154,277 | +19% | +$121M |
|
16
Amgen
AMGN
$155B
| $760M | 0.74% | 3,750,003 +590,465 | +19% | +$120M |
|
17
Novartis
NVS
$245B
| $700M | 0.68% | 8,491,408 +1,890,226 | +29% | +$156M |
|
18
Hershey
HSY
$37.3B
| $696M | 0.68% | 5,255,138 +764,076 | +17% | +$101M |
|
|
S
19
DELISTED
Sprint Corporation
S
| $675M | 0.66% | 78,342,305 -11,711,655 | -13% | -$101M |
|
20
Target
TGT
$43.6B
| $652M | 0.63% | 7,009,159 +1,337,191 | +24% | +$124M |
|
21
Domino's
DPZ
$15.6B
| $642M | 0.62% | 1,981,525 +275,425 | +16% | +$89.3M |
|
22
Fortinet
FTNT
$60.4B
| $614M | 0.6% | 6,064,388 +313,500 | +5% | +$31.7M |
|
23
Molina Healthcare
MOH
$9.8B
| $580M | 0.56% | 4,148,109 -23,400 | -0.6% | -$3.27M |
|
|
24
Baidu
BIDU
$32.8B
| $576M | 0.56% | 5,710,043 +3,793,066 | +198% | +$382M |
|
25
Duke Energy
DUK
$95.3B
| $573M | 0.56% | 7,078,432 +837,779 | +13% | +$67.8M |
|